These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 34375681)
1. Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer. Raguraman R; Srivastava A; Munshi A; Ramesh R Adv Drug Deliv Rev; 2021 Nov; 178():113918. PubMed ID: 34375681 [TBL] [Abstract][Full Text] [Related]
2. Drug delivery approaches for HuR-targeted therapy for lung cancer. Raguraman R; Shanmugarama S; Mehta M; Elle Peterson J; Zhao YD; Munshi A; Ramesh R Adv Drug Deliv Rev; 2022 Jan; 180():114068. PubMed ID: 34822926 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment. Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517 [TBL] [Abstract][Full Text] [Related]
4. Diabetes and Cancer: a Review of Current Knowledge. Wojciechowska J; Krajewski W; Bolanowski M; Kręcicki T; Zatoński T Exp Clin Endocrinol Diabetes; 2016 May; 124(5):263-75. PubMed ID: 27219686 [TBL] [Abstract][Full Text] [Related]
5. Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts. Shi J; Feng J; Xie J; Mei Z; Shi T; Wang S; Du Y; Yang G; Wu Y; Cheng X; Li S; Zhu L; Yang CS; Tu S; Jie Z Sci Rep; 2017 Aug; 7(1):8660. PubMed ID: 28819126 [TBL] [Abstract][Full Text] [Related]
6. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872 [TBL] [Abstract][Full Text] [Related]
7. Cadmium disrupts signaling of the hypoxia-inducible (HIF) and transforming growth factor (TGF-β) pathways in placental JEG-3 trophoblast cells via reactive oxygen species. Adebambo OA; Shea D; Fry RC Toxicol Appl Pharmacol; 2018 Mar; 342():108-115. PubMed ID: 29408318 [TBL] [Abstract][Full Text] [Related]
8. Activation of macrophage TBK1-HIF-1α-mediated IL-17/IL-10 signaling by hyperglycemia aggravates the complexity of coronary atherosclerosis: An in vivo and in vitro study. Li Q; Liu Y; Xia X; Sun H; Gao J; Ren Q; Zhou T; Ma C; Xia J; Yin C FASEB J; 2021 May; 35(5):e21609. PubMed ID: 33908659 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance. Asghariazar V; Sakhinia E; Mansoori B; Mohammadi A; Baradaran B J Cell Biochem; 2019 Dec; 120(12):19274-19289. PubMed ID: 31364210 [TBL] [Abstract][Full Text] [Related]
10. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Singh MK; Das BK; Choudhary S; Gupta D; Patil UK Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271 [TBL] [Abstract][Full Text] [Related]
11. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders. Laddha AP; Kulkarni YA Respir Med; 2019 Sep; 156():33-46. PubMed ID: 31421589 [TBL] [Abstract][Full Text] [Related]
12. Effect of alprostadil on myocardial fibrosis in rats with diabetes mellitus via TGF-β1/Smad signaling pathway. Tu JH; Xu Y; Dai Y; Dang L Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9633-9641. PubMed ID: 31773714 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells. Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: Biomarkers for cardiovascular disease in patients with diabetes mellitus. Briasoulis A; Tousoulis D; Vogiatzi G; Siasos G; Papageorgiou N; Oikonomou E; Genimata V; Konsola T; Stefanadis C Curr Top Med Chem; 2013; 13(13):1533-9. PubMed ID: 23745805 [TBL] [Abstract][Full Text] [Related]
15. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Catrina SB; Zheng X Diabetologia; 2021 Apr; 64(4):709-716. PubMed ID: 33496820 [TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies. Noskovičová N; Petřek M; Eickelberg O; Heinzelmann K Am J Respir Cell Mol Biol; 2015 Mar; 52(3):263-84. PubMed ID: 25303647 [TBL] [Abstract][Full Text] [Related]
18. Natural Alkaloids Intervening the Insulin Pathway: New Hopes for Anti-Diabetic Agents? Christodoulou MI; Tchoumtchoua J; Skaltsounis AL; Scorilas A; Halabalaki M Curr Med Chem; 2019; 26(32):5982-6015. PubMed ID: 29714135 [TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update. Al Kury LT; Abdoh A; Ikbariah K; Sadek B; Mahgoub M Molecules; 2021 Dec; 27(1):. PubMed ID: 35011414 [TBL] [Abstract][Full Text] [Related]
20. miR-126 as a Therapeutic Agent for Diabetes Mellitus. Pishavar E; Behravan J Curr Pharm Des; 2017; 23(22):3309-3314. PubMed ID: 28440196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]